A University of Toronto research team has created a new platform that delivers multiple therapeutic proteins to the body – each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50. In this diagram, the orange circle represents a new...
